Viracta Therapeutics Statistics
Total Valuation
VIRX has a market cap or net worth of $19.24 million. The enterprise value is -$1.47 million.
| Market Cap | 19.24M |
| Enterprise Value | -1.47M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, before market open.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
VIRX has 39.27 million shares outstanding. The number of shares has increased by 2.25% in one year.
| Shares Outstanding | 39.27M |
| Shares Change (YoY) | +2.25% |
| Shares Change (QoQ) | +1.37% |
| Owned by Insiders (%) | 2.76% |
| Owned by Institutions (%) | 51.87% |
| Float | 24.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.74 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 1.70.
| Current Ratio | 1.35 |
| Quick Ratio | n/a |
| Debt / Equity | 1.70 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.04 |
Financial Efficiency
Return on equity (ROE) is -191.60% and return on invested capital (ROIC) is -174.91%.
| Return on Equity (ROE) | -191.60% |
| Return on Assets (ROA) | -79.50% |
| Return on Capital (ROIC) | -174.91% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.20M |
| Employee Count | 40 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.49% in the last 52 weeks. The beta is 0.39, so VIRX's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | -64.49% |
| 50-Day Moving Average | 0.71 |
| 200-Day Moving Average | 0.73 |
| Relative Strength Index (RSI) | 34.17 |
| Average Volume (20 Days) | 124,057 |
Short Selling Information
The latest short interest is 708,880, so 1.81% of the outstanding shares have been sold short.
| Short Interest | 708,880 |
| Short Previous Month | 682,669 |
| Short % of Shares Out | 1.81% |
| Short % of Float | 2.87% |
| Short Ratio (days to cover) | 6.92 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -52.36M |
| Pretax Income | -47.99M |
| Net Income | -47.99M |
| EBITDA | -43.83M |
| EBIT | -44.31M |
| Earnings Per Share (EPS) | -$1.23 |
Balance Sheet
The company has $39.57 million in cash and $18.86 million in debt, giving a net cash position of $20.71 million or $0.53 per share.
| Cash & Cash Equivalents | 39.57M |
| Total Debt | 18.86M |
| Net Cash | 20.71M |
| Net Cash Per Share | $0.53 |
| Equity (Book Value) | 11.08M |
| Book Value Per Share | 0.28 |
| Working Capital | 10.70M |
Cash Flow
In the last 12 months, operating cash flow was -$36.40 million and capital expenditures -$138,000, giving a free cash flow of -$36.54 million.
| Operating Cash Flow | -36.40M |
| Capital Expenditures | -138,000 |
| Free Cash Flow | -36.54M |
| FCF Per Share | -$0.93 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VIRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.25% |
| Shareholder Yield | -2.25% |
| Earnings Yield | -249.38% |
| FCF Yield | -189.88% |
Analyst Forecast
The average price target for VIRX is $7.20, which is 1,369.39% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.20 |
| Price Target Difference | 1,369.39% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -31.87% |
Stock Splits
The last stock split was on February 25, 2021. It was a reverse split with a ratio of 285:1000.
| Last Split Date | Feb 25, 2021 |
| Split Type | Reverse |
| Split Ratio | 285:1000 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |